Sweden 3D Imaging Market Analysis Report 2022 to 2030

Sweden 3D Imaging Market Analysis

$ 3999

Sweden's 3D imaging market is projected to grow from $xx Bn in 2022 to $0.11 Bn by 2030, registering a CAGR xx% during the forecast period of 2022-30. The market will be driven by the increased frequency of chronic illnesses, the growing need for customized care & The Swedish government's efforts in healthcare and medical research. The market is segmented by product, application, by end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers, and Philips Healthcare

ID: IN10SEDH001 CATEGORY: Digital Health GEOGRAPHY: Sweden AUTHOR: Vidhi Upadhyay

Buy Now

Sweden 3D Imaging Market Executive Summary

Sweden's 3D imaging market is projected to grow from $0.11 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. Sweden's PPP health spending per capita increased from $ 5,655.7 in 2017 to $ 6,222.7 in 2019. Health spending in Sweden is mostly supported by local tax revenue, as well as direct payments from the national government, regional subsidies for outpatient prescriptions, and certain national programs. Its health spending was 10.9% of GDP, the third highest among EU nations and significantly higher than the EU average of 9.9%. According to The Global Cancer Observatory 2020, out of a total population of 10.09 Mn, the number of new cases of cancer was 0.062 Mn with 0.024 Mn deaths. Chronic ischemic heart disease was the leading cause of mortality from heart diseases in Sweden in 2021 claiming the lives of 51.52 people per 100,000 people.

Sweden has a well-established healthcare system that makes use of cutting-edge medical technology such as 3D Imaging. CT and MRI scans, for example, are widely utilized in Swedish hospitals and medical institutions for a variety of medical purposes, including cancer detection, neuroimaging, and orthopedic surgery planning. In Sweden, there have been many advancements in the field of 3D Imaging in recent years. Uppsala University, for example, has developed a revolutionary 3D printing technology that utilizes CT and MRI images to construct extremely realistic copies of patient-specific organs and tissues. Furthermore, Swedish medical technology businesses are creating new 3D imaging software and hardware, such as enhanced visualization software.

sweden 3D imaging market analysis

Market Dynamics

Market Growth Drivers

In November 2021, ContextVision, a medical technology software business specializing in image quality and artificial intelligence, announced the release of Rivent 3D, a breakthrough in ultrasound medical imaging technology. ContextVision extended the Rivent platform even further by giving physicians with 3D and 4D visuals that are as clear as reality, assisting them in delivering a confident diagnosis and improved treatment. Such technological advancements have resulted in improved accuracy and resolution, making the technology more dependable for medical applications. One of the top drivers is the growing need for customized care, which has necessitated the development of patient-specific models and treatment strategies. Furthermore, the increased frequency of chronic illnesses in Sweden has prompted the development of improved diagnosis and treatment technologies, such as 3D Imaging. The Swedish government's efforts in healthcare and medical research have also aided market expansion. Finally, Sweden's strong legacy of partnership between academics and business has fostered innovation in the field of 3D Imaging, adding to the country's growth and prosperity.

Market Restraints

A number of additional issues impede Sweden's 3D imaging market, including the high cost of 3D imaging technology, which inhibits its broad adoption in many healthcare facilities. The shortage of qualified staff capable of operating and interpreting complex 3D imaging equipment is a significant impediment. Furthermore, in Sweden, the rigorous regulatory requirements and lengthy approval process for new medical devices and imaging technologies provide a significant barrier to entry for new enterprises.

Competitive Landscape

Key Players

GE Healthcare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems
Fujifilm Holdings Corporation
Hitachi Healthcare
Toshiba Medical Systems
ContextVision AB (SWE)
Bildteknik (SWE)

Notable Deals

January 2023, Canon Medical Systems Corporation announced a Partnership with ScImage, Inc., as it plans to expand in image exchange solutions and the cardiac market
November 2022, At RSNA, Philips introduces new AI-enhanced informatics solutions having an integrated diagnostic strategy that combines radiology, cardiology, pathology, and oncology to securely unify data and pictures throughout the organization, allowing for an earlier and more conclusive diagnosis
November 2022, GE HealthCare announced partnerships with Accuray, Elekta, and RaySearch to combine GE HealthCare's imaging capabilities with precision radiation therapy to give cancer patients early diagnosis and improved treatment alternatives

Healthcare Policies and Regulatory Landscape

The Swedish Medical Products Agency (MPA), controls the safety, effectiveness, and quality of medical devices and equipment including 3D Imaging in Sweden. The MPA is in charge of authorizing and overseeing the use of 3D Imaging technology in clinical settings.

Reimbursement Scenario

Sweden's healthcare system offers universal population coverage for a wide range of services. As a result, the bulk of Out of pocket is due to cost-sharing regulations. The national healthcare system known as Swedish Social Insurance Agency is responsible for the reimbursement. As The Swedish healthcare system is publicly supported, and all people have free access to medical services such as 3D Imaging. Yet, certain types of imaging examinations may incur out-of-pocket fees for people who do not have health insurance.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Sweden 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

X-ray Imaging Systems
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

Cardiology
Neurology
Orthopedics
Gynecology
Oncology
Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

Hospitals
Diagnostic Imaging Centers
Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

Stationary
Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.